DASATINIB Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dasatinib, and when can generic versions of Dasatinib launch?
Dasatinib is a drug marketed by Apotex and is included in two NDAs.
The generic ingredient in DASATINIB is dasatinib. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dasatinib profile page.
Summary for DASATINIB
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 139 |
| Clinical Trials: | 357 |
| Patent Applications: | 3,095 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for DASATINIB |
| DailyMed Link: | DASATINIB at DailyMed |
Recent Clinical Trials for DASATINIB
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hospital Universitario Dr. Jose E. Gonzalez | Phase 2 |
| Fernando De la Garza Salazar | Phase 2 |
| Fight Kids Cancer | Phase 1/Phase 2 |
Medical Subject Heading (MeSH) Categories for DASATINIB
Anatomical Therapeutic Chemical (ATC) Classes for DASATINIB
US Patents and Regulatory Information for DASATINIB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | DASATINIB | dasatinib | TABLET;ORAL | 202103-001 | Jun 10, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Apotex | DASATINIB | dasatinib | TABLET;ORAL | 203180-001 | Nov 23, 2021 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Apotex | DASATINIB | dasatinib | TABLET;ORAL | 202103-002 | Jun 10, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Apotex | DASATINIB | dasatinib | TABLET;ORAL | 202103-003 | Jun 10, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Apotex | DASATINIB | dasatinib | TABLET;ORAL | 203180-002 | Nov 23, 2021 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
